Pfizer Wirthdraws Sickle Cell Drug Oxbryta Following Clinical Trial Deaths
An article over at Genetic Engineering & Biotechnology News reports that Pfizer has withdrawn its sickle cell disease medication Oxbryta after the European Medicines Agency (EMA) disclosed the deaths of…